Israel Englander Adicet Bio, Inc. Call Options Transaction History

Millennium Management LLC

  • $224 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
BUY
$5.52 - $9.23 $563,040 - $941,460
102,000 Added 204.0%
152,000 $876,000
Q4 2022

Feb 14, 2023
SELL
$7.72 - $21.27 $424,600 - $1.17 Million
-55,000 Reduced 52.38%
50,000 $447,000
Q3 2022

Nov 14, 2022
BUY
$13.43 - $18.74 $1.41 Million - $1.97 Million
105,000 New
105,000 $1.49 Million

Others Institutions Holding ACET

# of Institutions
107
Shares Held
69.5M
Call Options Held
13.3K
Put Options Held
24.6K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $43.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email